Literature DB >> 1345304

[Presence of antibodies against Toxoplasma gondii in adolescents from the African continent].

R López1, R Contreras, L Font, O Vega.   

Abstract

It was determined the presence of antibodies anti-T. gondii in young, 13-16 year old, belonging to Republic Arab Saharaui; Popular Republic of Angola; Ethiopia and Republic of Ghana. From a total of 707 sera analyzed, the 71.43% of them showed the presence of specific antibodies. The prevalence of antibodies did not differ significantly (P > 0.05) between males and females in Angola and Republic Arab Saharaui. It was found a significant difference (P < 0.0001) among countries.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1345304

Source DB:  PubMed          Journal:  Rev Latinoam Microbiol        ISSN： 0187-4640


  5 in total

1.  Toxoplasmosis in dogs: first report of Toxoplasma gondii infection in any animal species in Angola.

Authors:  Ana Patrícia Lopes; Sara Granada; Ana Cristina Oliveira; Hugo Brancal; Jitender P Dubey; Luís Cardoso; Hugo Vilhena
Journal:  Pathog Glob Health       Date:  2014-11-13       Impact factor: 2.894

2.  Sero-epidemiology and risk factors for Toxoplasma gondii among pregnant women in Arab and African countries.

Authors:  Mohamed Alkhatim Alsammani
Journal:  J Parasit Dis       Date:  2014-09-20

3.  Portugal and Angola: similarities and differences in Toxoplasma gondii seroprevalence and risk factors in pregnant women.

Authors:  M L Lobo; G Patrocinio; T Sevivas; B DE Sousa; O Matos
Journal:  Epidemiol Infect       Date:  2016-09-09       Impact factor: 4.434

Review 4.  A Review on the Present Advances on Studies of Toxoplasmosis in Eastern Africa.

Authors:  John Mokua Mose; John Maina Kagira; David Muchina Kamau; Naomi Wangari Maina; Maina Ngotho; Simon Muturi Karanja
Journal:  Biomed Res Int       Date:  2020-07-06       Impact factor: 3.411

5.  Serological prevalence of toxoplasmosis in pregnant women in Luanda (Angola): Geospatial distribution and its association with socio-demographic and clinical-obstetric determinants.

Authors:  Amélia Nkutxi Vueba; Clarissa Perez Faria; Ricardo Almendra; Paula Santana; Maria do Céu Sousa
Journal:  PLoS One       Date:  2020-11-06       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.